Provided by Tiger Trade Technology Pte. Ltd.

Absci Corporation.

2.94
-0.0200-0.68%
Volume:3.30M
Turnover:9.68M
Market Cap:442.09M
PE:-3.28
High:3.04
Open:3.00
Low:2.86
Close:2.96
52wk High:5.23
52wk Low:2.01
Shares:150.37M
Float Shares:127.00M
Volume Ratio:0.53
T/O Rate:2.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8966
EPS(LYR):-0.9353
ROE:-55.68%
ROA:-30.62%
PB:2.10
PE(LYR):-3.14

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday

Absci Corp expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
Mar 21

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 20

Absci Price Target Maintained With a $7.00/Share by Needham

Dow Jones
·
Mar 18

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 18

BRIEF-Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Mar 07

Absci names Ransi Somaratne chief medical officer as Andreas Busch set to retire

Reuters
·
Mar 07

Absci Grants 650,000-Share Inducement Stock Option to New CMO Dr. Ransi Somaratne

Reuters
·
Mar 07

Absci Director Menelas N Pangalos Acquires Common Shares

Reuters
·
Mar 04

BRIEF-Absci Strengthens Clinical Leadership With Appointment Of Ransi Somaratne, M.D., FACC, Mba As Chief Medical Officer

Reuters
·
Mar 03

Absci Strengthens Clinical Leadership With Appointment of Ransi Somaratne, M.d., Facc, MBA as Chief Medical Officer

THOMSON REUTERS
·
Mar 03

Press Release: Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Dow Jones
·
Mar 03

Absci Corporation Updates Financial Calendar

Reuters
·
Feb 24

11 Stocks That Have Cratered and Look Like Buys -- Barrons.com

Dow Jones
·
Feb 10

Insiders Who Purchased US$582.6k Of Absci Stock May Not Have Expected 17% Tumble

Simply Wall St.
·
Feb 06

The Genesis Mission Has a 270-Day Timeline – And You’re Already Late

InvestorPlace
·
Jan 27

Absci Corporation showcases AI-driven antibody discovery and new clinical-stage drug programs

Reuters
·
Jan 15

Absci downgraded to Equal Weight from Overweight at Morgan Stanley

TIPRANKS
·
Jan 08

Absci Price Target Maintained With a $7.00/Share by Needham

Dow Jones
·
Dec 12, 2025

Absci Unveils AI-Designed Antibody That Stimulates Human Hair Growth

Reuters
·
Dec 11, 2025